Friday, December 27, 2013

Tandem Repeat Modification during Double-Strand Break Repair Induced by an Engineered TAL Effector Nuclease in Zebrafish Genome

Tandem Repeat Modification during Double-Strand Break Repair Induced by an Engineered TAL Effector Nuclease in Zebrafish Genome. Huang W, Zheng J, He Y, Luo, PLoS ONE 8(12): e84176. doi:10.1371/journal.pone.0084176

FULL TEXT PDF

Dysphagia and swallowing-related quality of life in Friedreich ataxia

Dysphagia and swallowing-related quality of life in Friedreich ataxia. Adam P. Vogel, Sophie E. Brown, Joanne E. Folker, Louise A. Corben, Martin B. Delatycki;
Journal of Neurology, December 2013. DOI 10.1007/s00415-013-7208-4

Keywords: Dysphagia, Friedreich ataxia (FRDA), quality of life, oral-motor examination, speech and swallowing, incoordination, weakness, spasticity.

Role of Frataxin, a Protein Implicated in Friedreich Ataxia, in Making Iron-Sulfur Clusters

Role of Frataxin, a Protein Implicated in Friedreich Ataxia, in Making Iron-Sulfur Clusters. The Journal of Biological Chemistry, 288, 36787. December 27, 2013; 10.1074/jbc.P113.525857

The authors concluded that their work “may help develop a drug for treating Friedreich ataxia associated with frataxin deficiency.”

See referenced article: Frataxin Directly Stimulates Mitochondrial Cysteine Desulfurase by Exposing Substrate-binding Sites, and a Mutant Fe-S Cluster Scaffold Protein with Frataxin-bypassing Ability Acts Similarly. J. Biol. Chem. 2013, 288, 36773–36786.

Friday, December 20, 2013

Thursday, December 19, 2013

Erythropoietin and the heart: Physiological effects and the therapeutic perspective

Erythropoietin and the heart: Physiological effects and the therapeutic perspective. Fabian Sanchis-Gomar, José Luis Garcia-Gimenez, Helios Pareja-Galeano, Marco Romagnoli, Carme Perez-Quilis, Giuseppe Lippi; International Journal of Cardiology, Available online 18 December 2013, http://dx.doi.org/10.1016/j.ijcard.2013.12.011

Keywords: Myocardial infarction; cardioprotection; remodelling; EpoR; angiogenesis; apoptosis; inflammation; pleiotropic actions; Friedreich’s ataxia

If rhEpo or its analogues improve(s) the muscle and mitochondrial function it would help improve the cardiac function. However, none of these studies and clinical trials mentioned the long-term effect of rhEpo on the heart of FRDA. Thus, an effort designing a clinical trial involving treatments a long term in FRDA patients are strongly recommended.

Wednesday, December 18, 2013

The role of iron and reactive oxygen species in cell death

The role of iron and reactive oxygen species in cell death. Scott J Dixon & Brent R Stockwell; Nature Chemical Biology, 10, 9–17(2014), doi:10.1038/nchembio.1416; Published online 17 December 2013

Keywords: iron, potentially toxic iron-catalyzed reactive oxygen species (ROS), cell death, ferroptosis, cancer, organ damage,degenerative disease.

Sunday, December 15, 2013

Vitamin E is essential for Purkinje neuron integrity

Vitamin E is essential for Purkinje neuron integrity. L. Ulatowski, R. Parker, G. Warrier, R. Sultana, D.A. Butterfield, D. Manor; Neuroscience, Available online 14 December 2013. http://dx.doi.org/10.1016/j.neuroscience.2013.12.001

Keywords: Vitamin E; Tocopherol; Purkinje neuron; Cerebellum; Ataxia; Oxidative stress

Wednesday, December 11, 2013

Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells

Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells. Yee-Ki Lee, Philip Wing-Lok Ho, Revital Schick, Yee-Man Lau, Wing-Hon Lai, Ting Zhou, Yanhua Li, Kwong-Man Ng, Shu-Leung HO, Miguel Angel Esteban,
Ofer Binah, Hung-Fat Tse, Chung-Wah Siu; Pflügers Archiv - European Journal of Physiology, December 2013

Keywords: Friedreich ataxia (FRDA), hypertrophic cardiomyopathy, frataxin, FRDA-cardiac cellular models, iron homeostasis, calcium homeostasis, contractile force.

REGIONAL SIDEROSIS: A NEW CHALLENGE FOR IRON CHELATION THERAPY

REGIONAL SIDEROSIS: A NEW CHALLENGE FOR IRON CHELATION THERAPY. Cabantchik Zvi Ioav, Munnich Arnold, Youdim Moussa B., Devos David; Frontiers in Pharmacology, Paper pending published: 09 Dec 2013

Keywords: Iron, chelation, neurodegeneration, Anemia, Friedreich Ataxia, Parkinson Disease, deferiprone

Saturday, December 7, 2013

Italy blocks controversial stem cell therapy

Italy blocks controversial stem cell therapy. Nature Biotechnology 31, 1062 (2013); doi:10.1038/nbt1213-1062a
Published online 06 December 2013

The Italian government withdrew its support for a controversial stem cell therapy trial before it was due to start, prompting an outcry from patients. The decision was announced by Health Minister Beatrice Lorenzin on October 10, after an ad hoc scientific committee deemed the treatment too risky and undefined. In…